Fractyl Health, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GUTS | BMEA | MTVA | CELU | BRTX | DMYD-B.ST | |
|---|---|---|---|---|---|---|
| Market cap | 12.90M | 44.24M | 8.83M | 26.25M | 2.09M | 150.64M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.3 | -0.7 | — | -1.4 | -0.1 | — |
| Price/book | -7.7 | 3.7 | 1.3 | -0.7 | 0.6 | 0.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −93.38% | −53.43% | −88.55% | −55.60% | −94.93% | −90.43% |
| Today | +8.27% | −1.91% | +6.35% | −1.02% | +2.03% | −2.51% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All GUTS news ›Chubb Sued by Pharmaceutical Ingredient Firm Over Injury Cases
Bloomberg Law News A Massachusetts pharmaceutical ingredient distributor sued its insurer, a Chubb Ltd. unit, for refusing to cover its defense and settlement costs in a wave of personal injury lawsuits tied to Moringa leaf powder, a pro
Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance
Following positive topline six-month REMAIN-1 pivotal results, Revita advancing toward planned FDA De Novo submission in late Q4 2026 and anticipated 12-month pivotal data readout in Q1 2027 Company discontinuing development of Rejuva…
Fractyl strengthens patent portfolio for Revita
Fractyl has expanded its U.S. patent portfolio for the Revita DMR system as it advances toward a planned U.S. Food and Drug Administration De Novo marketing submission for post-GLP-1 weight maintenance. According to the company, U.S.…
Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization
The U.S. Patent and Trademark Office (USPTO) has issued a patent covering aspects of Revita’s single-use catheter and allowed a patent application covering how the system controls thermal energy during treatment. These developments…
Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation
REMAIN-1 met its six-month co-primary endpoint with high statistical significance (p=0.0023; mITT population); demonstrated 80% retention of GLP-1 induced weight loss vs 67% for sham 32% of Revita® participants in primary analysis…
H.C. Wainwright Keeps Their Buy Rating on Fractyl Health, Inc. (GUTS)
H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Fractyl Health, Inc. today and set a price target of $8.00. Pantginis covers the Healthcare sector, focusing on stocks such as Cytokinetics, Pharming Group, and Rigel.…
Fractyl Health, Inc. (NASDAQ:GUTS) Stock Short Interest Falls 87.7%
Posted by Kim Johansen on Oct 27th, 2026 Fractyl Health (NASDAQ:GUTS – Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The company reported ($1.44) earnings per share for the quarter, topping the…
Fractyl’s Weight Maintenance Device Meets Clinical Goal, but Shares Nosedive, Layoffs Follow
Fractyl Health reported positive six-month trial results from an investigation of its Revita procedure last week, but shares of Fractyl stock dropped steeply on October 16 immediately following the announcement. Despite the positive…
Fractyl Health plans 45% job cut to fund Revita FDA submission
The developer will stop internal Rejuva gene-therapy work and forecasts cash into Q2 2027, ahead of a potential 2028 launch. A planned 45 per cent workforce cut will concentrate resources on an obesity device as Fractyl Health, Inc.…
Fractyl Health plans approximately 45% workforce cut
T1 Receives Commerce Department Polysilicon 232 Waiver American Fusion™ Advances Texatron™ Commercialization With Four New Texas Data Center Proposals, New Research Facility, Planned North Texas Research Campus and Investment Banking…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- globenewswire.com13
- markets.businessinsider.com7
- prnewswire.com7
- accessnewswire.com5
- natlawreview.com4
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 62 articles, not a forecast.